<DOC>
	<DOCNO>NCT02221973</DOCNO>
	<brief_summary>The aim LipiDown ( Hawthorn + Phytosterol ) clinical trial test blood lipid reduction effect plant sterols hawthorn milk powder pilot human trial : demonstrate potential reduce total blood cholesterol 10 % and/or total triglyceride 15 % , require State food drug administration ( SFDA ) regulation .</brief_summary>
	<brief_title>Effect Low Fat Milk Product Lipids Profile Dyslipidemia Subjects</brief_title>
	<detailed_description>The propose clinical trial pilot randomize , double-blind , placebo control , parallel , multicenter study three treatment group . The total number 75 subject enrol provide 20 % dropout rate . Subjects randomized one follow 3 group : - milk without sterol hawthorn powder - milk 1.2g/d sterol 8g/d hawthorn powder - milk 1.8g/d sterol 8g/d hawthorn powder The trial population consist female male volunteer age 18 - 65 year age primary mild moderate hyperlipidemia document serum cholesterol 5.18-6.21mmol/L AND serum Triglycerides ( TG ) : 1.7-5.65mmol/L , least 1 time tested central laboratory past 2 week prior recruitment .</detailed_description>
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>Chinese male female 18 65 year old ( inclusive ) . Fasting Serum TC : 5.186.21mmol/L ( equal 200241 mg/dl ) AND Serum TG : 1.75.65mmol/L ( equal 150 500 mg/dl ) least 1 time tested central laboratory past 2 week prior recruitment . Primary dyslipidemia . The subject demonstrate understand give information ability record request data . Having obtain his/her inform consent BMI 32 kg/m2 ( morbid obesity ) . Pregnant lactate woman intent get pregnant . Menopause woman hormonal replacement therapy . Familial hyperlipidemia . Identified food allergy dairy product lactose intolerance . Severe disease heart , liver , kidney hematopoietic system admission . History angina , myocardial infarction , coronary artery bypass , heart failure cardiovascular instability last 6 month . History diabetes , GI , renal , pulmonary , hepatic biliary , hypothyroidism , mental disease selfcontrol capacity articulate . Subject currently take drug interfere lipid profile , include limited statin , nicotinic acid , bile acid sequestrant , fibric acid , policosanol tablet . Subject receive antihyperlipidemia medication past 4 week . Subject regularly take supplement function lipid reduction past 3 month take study ( e.g . plant sterol , omega3 fish oil , betaglucan , nutrich diet , soy protein , soluble oat fiber , red yeast rice cholesterol reduce functional ingredient ) . Inpatient hyperlipidemia subject . Alcohol &gt; 3 glass wine , 2 beer , 1 shot hard alcohol/day . Subject expect comply study procedure . Subject currently participate participate another clinical trial last 4 week prior begin study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>